Deal Watch: GSK Furthers Cancer Gene Therapy Plans Via Lyell Collaboration
Executive Summary
GSK hopes the San Francisco biotech’s technology can help its cell therapy pipeline address solid tumors. Avacta partners with ADC on antibody-drug conjugates.